Literature DB >> 4325867

Antiviral activity of polyribocytidylic acid in cells primed with polyriboinosinic acid.

E De Clercq, P De Somer.   

Abstract

Separate administration of polyribocytidylic acid [poly(rC)] and polyriboinosinic acid [poly(rI)] to cell cultures in vitro resulted in an antiviral activity identical to or greater than that resulting from addition of the poly(rI) * poly(rC) complex. Priming of cells with poly(rI), followed by treatment with poly(rC), gave a consistently greater antiviral activity than poly(rI) * poly(rC) itself. This priming effect was obtained in several cell cultures challenged with different viruses. In vivo, the antiviral activity of poly(rI) * poly(rC) was only partially restored if poly(rI) and poly(rC) were injected separately; prior injection of poly(rI) proved superior in restoring this antiviral activity as compared to prior injection of poly(rC).

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4325867     DOI: 10.1126/science.173.3993.260

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Interferon induction by synthetic polynucleotides: importance of purine N-7 and strandwise rearrangement.

Authors:  E De Clercq; P F Torrence; B Witkop
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

2.  Anti-viral activity against encephalomyocarditis virus and Semliki Forest virus and acute toxicity of poly I and poly C administered sequentially to mice.

Authors:  N Stebbing; C A Grantham
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

3.  Mechanism of the antiviral activity resulting from sequential administration of complementary homopolyribonucleotides to cell cultures.

Authors:  E De Clercq; P De Somer
Journal:  J Virol       Date:  1972-05       Impact factor: 5.103

Review 4.  An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014.

Authors:  Erik De Clercq
Journal:  Acta Pharm Sin B       Date:  2015-11-02       Impact factor: 11.413

Review 5.  Interferon and its inducers--a never-ending story: "old" and "new" data in a new perspective.

Authors:  Erik De Clercq
Journal:  J Infect Dis       Date:  2006-09-15       Impact factor: 5.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.